Humana Is First Commercial Payer to Address TMS Therapy Coverage for Adolescents GlobeNewswire
Market data is delayed by at least 15 minutes.
    Latest Story Top Stories on STIM
    No News Available
    Neuronetics Reports Record First Quarter 2024 Financial and Operating...
    7:30a ET May 7 '24 GlobeNewswire
    Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c...
    4:30p ET May 3 '24 GlobeNewswire
    NeuroStar(R) TMS Advances Treatment for Adolescents During Mental Hea...
    8:31a ET May 1 '24 GlobeNewswire
    Neuronetics to Report First Quarter 2024 Financial and Operating Resu...
    4:30p ET April 23 '24 GlobeNewswire
    New Publication in Brain Stimulation Confirms Full TMS Treatment Cour...
    8:31a ET April 10 '24 GlobeNewswire
    Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c...
    4:30p ET March 27 '24 GlobeNewswire
    NeuroStar(R) Advanced Therapy Receives FDA Clearance as a First-Line ...
    8:30a ET March 25 '24 GlobeNewswire
    Neuronetics Announces 5-Year Exclusive Partnership with Transformatio...
    8:22a ET March 7 '24 GlobeNewswire
    Neuronetics Reports Record Fourth Quarter and Record Full Year 2023 F...
    7:30a ET March 5 '24 GlobeNewswire
    Neuronetics to Report Fourth Quarter 2023 Financial and Operating Res...
    8:30a ET February 20 '24 GlobeNewswire

    Market data provided by News provided by